T. van Staa

First name
T.
Middle name
P.
Last name
van Staa
van Staa, T. P., Wegman, S., de Vries, F., Leufkens, B., & Cooper, C. (2001). Use of statins and risk of fractures. Jama.
View
van Staa, T. P., Leufkens, H. G., & Cooper, C. (2001). Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res. http://doi.org/10.1359/jbmr.2001.16.3.581
View
van Staa, T. P., Abenhaim, L., Cooper, C., Zhang, B., & Leufkens, H. G. (2001). Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol.
View
van Staa, T. P., Dennison, E. M., Leufkens, H. G., & Cooper, C. (2001). Epidemiology of fractures in England and Wales. Bone.
View
van Staa, T. P., Leufkens, H. G., & Cooper, C. (2002). Utility of medical and drug history in fracture risk prediction among men and women. Bone.
View
van Staa, T. P., Leufkens, H. G., & Cooper, C. (2002). Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int. http://doi.org/10.1007/s001980200084
View
van Staa, T. P., Selby, P., Leufkens, H. G., Lyles, K., Sprafka, J. M., & Cooper, C. (2002). Incidence and natural history of Paget\textquoterights disease of bone in England and Wales. J Bone Miner Res. http://doi.org/10.1359/jbmr.2002.17.3.465
View
van Staa, T. P., Cooper, C., Leufkens, H. G., & Bishop, N. (2003). Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res. http://doi.org/10.1359/jbmr.2003.18.5.913
View
van Staa, T. P., Boulton, F., Cooper, C., Hagenbeek, A., Inskip, H., & Leufkens, H. G. (2003). Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. Am J Hematol. http://doi.org/10.1002/ajh.10295
View
Souverein, P. C., van Staa, T. P., Egberts, A. C., De la Rosette, J. J., Cooper, C., & Leufkens, H. G. (2003). Use of alpha-blockers and the risk of hip/femur fractures. J Intern Med.
View